Clinical Trial Update: A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China

View source ↗

Summary

An observational study in China evaluating Deucravacitinib for moderate plaque psoriasis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Plaque Psoriasis | Status: ACTIVE_NOT_RECRUITING